Drug manufacturer Forest Laboratories, Inc. (FRX) announced results for the most recent quarter that surpassed expectations. More importantly, the company's new CEO announced aggressive cost cutting targets and a $1 billion share buyback plan.
From Diamond Hill Capital (Trades, Portfolio)'s Select Fund Commentary for fourth quarter 2013.